UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 283

Sortiert nach

Multidisciplinary team meetings in Hematology: a national mixed-methods study

BMC cancer, 2023-10, Vol.23 (1), p.1-950, Article 950

2023

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

Blood, 2010-09, Vol.116 (12), p.2040-2045

2010

Link zum Volltext

Verfügbarkeit prüfen

A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission

Blood, 2012-11, Vol.120 (22), p.4317-4323

2012

Link zum Volltext

Verfügbarkeit prüfen

Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura

Blood, 2014-07, Vol.124 (2), p.204-210

2014

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Impact of Isocitrate Dehydrogenase Enzyme Isoforms 1 and 2 Mutations in Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group

Journal of clinical oncology, 2010-08, Vol.28 (23), p.3717-3723

2010

Link zum Volltext

Verfügbarkeit prüfen

Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic Purpura

Medicine (Baltimore), 2015-10, Vol.94 (42), p.e1598-e1598

2015

Link zum Volltext

Verfügbarkeit prüfen

Superior Long-Term Outcome With Idarubicin Compared With High-Dose Daunorubicin in Patients With Acute Myeloid Leukemia Age 50 Years and Older

Journal of clinical oncology, 2013-01, Vol.31 (3), p.321-327

2013

Link zum Volltext

Verfügbarkeit prüfen

c-Rel Is the Pivotal NF-κB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: A LYSA Study

Frontiers in oncology, 2021-04, Vol.11, p.638897-638897

2021

Link zum Volltext

Verfügbarkeit prüfen

Analysis of the Ten-Eleven Translocation 2 (TET2) gene in familial myeloproliferative neoplasms

Blood, 2009-08, Vol.114 (8), p.1628-1632

2009

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Follow-Up of Patients With Newly Diagnosed Follicular Lymphoma in the Prerituximab Era: Effect of Response Quality on Survival—A Study From the Groupe d'Etude des Lymphomes de l'Adulte

Journal of clinical oncology, 2010-02, Vol.28 (5), p.822-829

2010

Link zum Volltext

Verfügbarkeit prüfen

Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? experience of the French thrombotic microangiopathies reference center

American journal of hematology, 2015-06, Vol.90 (6), p.E127-E129

2015

Link zum Volltext

Verfügbarkeit prüfen

Endogenous neurotrophins and Trk signaling in diffuse large B cell lymphoma cell lines are involved in sensitivity to rituximab-induced apoptosis

PloS one, 2011-11, Vol.6 (11), p.e27213-e27213

2011

Link zum Volltext

Verfügbarkeit prüfen

Involvement of Human Herpesvirus-6 Variant B in Classic Hodgkin's Lymphoma via DR7 Oncoprotein

Clinical cancer research, 2010-10, Vol.16 (19), p.4711-4721

2010

Link zum Volltext

Verfügbarkeit prüfen

Low-Dose Thalidomide Ameliorates Cytopenias and Splenomegaly in Myelofibrosis With Myeloid Metaplasia: A Phase II Trial

Journal of clinical oncology, 2004-02, Vol.22 (3), p.424-431

2004

Link zum Volltext

Verfügbarkeit prüfen

Obtaining informed consent: real ethic thoughts for hematologists in daily relationships with patients for care or clinical research

Hématologie, 2018-01, Vol.24 (1), p.72-81

Bordessoule, Dominique

2018

Link zum Volltext

Verfügbarkeit prüfen

High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome

Blood, 2002-04, Vol.99 (8), p.3057-3059

2002

Link zum Volltext

Verfügbarkeit prüfen

mPGES-1 in leukemic cells of AML patients

International journal of hematology, 2012, Vol.95 (1), p.115-116

2012

Link zum Volltext

Verfügbarkeit prüfen

Hepatocyte growth factor measurement in AL amyloidosis

Amyloid, 2015-06, Vol.22 (2), p.112-116

2015

Link zum Volltext

Verfügbarkeit prüfen

Accompanying patients’ autonomy with blood disease in their care pathways

Hématologie, 2017-01, Vol.23 (1), p.79-85

Bordessoule, Dominique

2017

Link zum Volltext

Verfügbarkeit prüfen

Non-invasive detection of hepatic amyloidosis: FibroScan, a new tool

Amyloid, 2011-03, Vol.18 (1), p.19-24

2011

Link zum Volltext

Verfügbarkeit prüfen

Ethical and Clinical Aspects of Intensive Care Unit Admission in Patients with Hematological Malignancies: Guidelines of the Ethics Commission of the French Society of Hematology

Advances in hematology, 2014, Vol.2014, p.1-8

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 283

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(266)
Mit Volltextzugriff
(257)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(137)
Life Sciences & Biomedicine
(132)
Humans
(131)
Female
(96)
Male
(96)
Middle Aged
(89)
Hematology
(84)
Life Sciences
(82)
Aged
(81)
Adult
(73)
Immunology
(65)
Biological And Medical Sciences
(60)
Medical Sciences
(56)
Oncology
(55)
Hematologic And Hematopoietic Diseases
(39)
Aged, 80 And Over
(38)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(32)
Treatment Outcome
(29)
Prognosis
(28)
Adolescent
(25)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multidisciplinary team meetings in Hematology: a national mixed-methods study

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte

A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study

Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial

Prognostic Impact of Isocitrate Dehydrogenase Enzyme Isoforms 1 and 2 Mutations in Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group

Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience

Randomized Study of Intensified Anthracycline Doses for Induction and Recombinant Interleukin-2 for Maintenance in Patients With Acute Myeloid Leukemia Age 50 to 70 Years: Results of the ALFA-9801 Study

Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic Purpura

Superior Long-Term Outcome With Idarubicin Compared With High-Dose Daunorubicin in Patients With Acute Myeloid Leukemia Age 50 Years and Older

c-Rel Is the Pivotal NF-κB Subunit in Germinal Center Diffuse Large B-Cell Lymphoma: A LYSA Study

Analysis of the Ten-Eleven Translocation 2 (TET2) gene in familial myeloproliferative neoplasms

Long-Term Follow-Up of Patients With Newly Diagnosed Follicular Lymphoma in the Prerituximab Era: Effect of Response Quality on Survival—A Study From the Groupe d'Etude des Lymphomes de l'Adulte

Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? experience of the French thrombotic microangiopathies reference center

Endogenous neurotrophins and Trk signaling in diffuse large B cell lymphoma cell lines are involved in sensitivity to rituximab-induced apoptosis

Involvement of Human Herpesvirus-6 Variant B in Classic Hodgkin's Lymphoma via DR7 Oncoprotein

Low-Dose Thalidomide Ameliorates Cytopenias and Splenomegaly in Myelofibrosis With Myeloid Metaplasia: A Phase II Trial

Obtaining informed consent: real ethic thoughts for hematologists in daily relationships with patients for care or clinical research

High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome

mPGES-1 in leukemic cells of AML patients

Hepatocyte growth factor measurement in AL amyloidosis

Accompanying patients’ autonomy with blood disease in their care pathways

Non-invasive detection of hepatic amyloidosis: FibroScan, a new tool

Ethical and Clinical Aspects of Intensive Care Unit Admission in Patients with Hematological Malignancies: Guidelines of the Ethics Commission of the French Society of Hematology

Suchergebnisse filtern